🚨#COSOSEC ALERT 🚨
GSK Plc will pay 23andMe Holding Co. $20 million for access to the genetic-testing company’s vast trove of consumer DNA data, extending a five-year collaboration that’s allowed the drugmaker to mine genetic data as it researches new medications.
@voltronic good and bad. There's a lot of medications that do better when we know there's a genetic component involved and who's at risk and treat earlier. Family history is no joke. Could be trying to see if some diseases are truly passed on and in what genetic pattern. There's a couple disorders in my family they are actively trying to figure out. Or for chronic pain people who aren't believed, this could be big.
But I understand fears of info getting out but we have to start somewhere.
@insomniacviolin
I'm not disputing any of that, but DNA data can often wind up places people don't expect. Law enforcement databases, for example.